|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.57 EUR | -0.50% |
|
-4.13% | -18.81% |
| 11-18 | SIEMENS HEALTHINEERS : UBS reiterates its Neutral rating | ZD |
| 11-18 | Squirrel Media Appoints New Chief Marketing Officer | MT |
| Capitalization | 46.22B 53.53B 42.8B 40.71B 74.84B 4,739B 82.21B 507B 196B 2,269B 201B 197B 8,323B | P/E ratio 2025 |
24.1x | P/E ratio 2026 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise value | 58.79B 68.08B 54.43B 51.78B 95.18B 6,027B 105B 645B 249B 2,886B 255B 250B 10,586B | EV / Sales 2025 |
2.19x | EV / Sales 2026 * | 2.36x |
| Free-Float |
23.56% | Yield 2025 * |
2.53% | Yield 2026 * | 2.62% |
Last Transcript: Siemens Healthineers AG
| 1 day | -0.50% | ||
| 1 week | -4.13% | ||
| Current month | -14.41% | ||
| 1 month | -13.00% | ||
| 3 months | -11.68% | ||
| 6 months | -15.76% | ||
| Current year | -18.81% |
| 1 week | 41.05 | 45.18 | |
| 1 month | 41.05 | 49.71 | |
| Current year | 41.05 | 58.48 | |
| 1 year | 41.05 | 58.48 | |
| 3 years | 41.05 | 58.48 | |
| 5 years | 36.92 | 67.66 | |
| 10 years | 28.5 | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bernhard Montag
CEO | Chief Executive Officer | 56 | 2015-01-31 |
Jochen Schmitz
DFI | Director of Finance/CFO | 59 | 2017-11-30 |
Peter Schardt
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 2018-02-28 | |
| Chairman | 64 | 2019-11-30 | |
Marion Helmes
BRD | Director/Board Member | 59 | 2018-02-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.50% | -4.13% | -17.16% | -18.97% | 53.88B | ||
| +1.56% | -0.06% | +12.27% | +8.71% | 213B | ||
| +0.01% | -5.11% | +3.63% | +109.68% | 194B | ||
| +2.30% | +6.79% | -2.16% | -13.14% | 156B | ||
| -2.50% | -1.67% | +14.06% | +135.12% | 151B | ||
| -0.83% | -0.05% | +24.03% | +14.00% | 49.17B | ||
| -0.47% | -1.72% | +13.20% | -0.42% | 40.97B | ||
| +0.62% | -1.55% | +4.89% | +12.44% | 35.72B | ||
| +0.33% | -1.26% | -23.63% | -34.15% | 35.06B | ||
| +0.55% | -3.35% | -13.14% | - | 32.17B | ||
| Average | -0.16% | -1.24% | +1.60% | +23.70% | 96.04B | |
| Weighted average by Cap. | -0.17% | -1.00% | +5.02% | +43.46% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 23.53B 27.25B 21.79B 20.72B 38.09B 2,412B 41.85B 258B 99.67B 1,155B 102B 100B 4,237B | 24.21B 28.03B 22.41B 21.32B 39.19B 2,482B 43.06B 265B 103B 1,188B 105B 103B 4,359B |
| Net income | 2.25B 2.6B 2.08B 1.98B 3.64B 230B 4B 24.65B 9.52B 110B 9.76B 9.56B 405B | 2.31B 2.67B 2.14B 2.03B 3.74B 237B 4.11B 25.32B 9.78B 113B 10.03B 9.82B 416B |
| Net Debt | 12.57B 14.55B 11.64B 11.07B 20.35B 1,288B 22.35B 138B 53.23B 617B 54.57B 53.44B 2,263B | 11.01B 12.75B 10.19B 9.69B 17.82B 1,128B 19.58B 121B 46.62B 540B 47.79B 46.81B 1,982B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-11-18 | 41.57 € | -0.50% | 1,458,497 |
| 25-11-17 | 41.78 € | -4.76% | 1,812,338 |
| 25-11-14 | 43.87 € | +1.27% | 1,458,907 |
| 25-11-13 | 43.32 € | -3.35% | 1,873,246 |
| 25-11-12 | 44.82 € | +0.88% | 872,008 |
Delayed Quote Xetra, November 18, 2025 at 11:35 am
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SHL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















